Full Text View
Tabular View
No Study Results Posted
Related Studies
Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
This study is ongoing, but not recruiting participants.
Study NCT00623974   Information provided by M.D. Anderson Cancer Center
First Received: February 14, 2008   Last Updated: April 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypocalcemia
More general conditions related to this trial
Calcium Metabolism Disorders
Metabolic Diseases
Water-Electrolyte Imbalance
Interventions listed in this trial
Teriparatide (Forteo)
Calcium
Calcitriol
Additional drug interventions recognized in this trial
Teriparatide
More general drug interventions related to this trial
Bone Density Conservation Agents
Calcium Channel Agonists
Cardiovascular Agents
Growth Substances
Membrane Transport Modulators
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Vitamins
Sponsors listed in this trial
M.D. Anderson Cancer Center
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services